Fractyl Health (GUTS)CEO sold ~$41K

~$41K

Approx. value · 21K sh @ $1.95

491K

Holds after · shares reported

Traded

Jan 30, 2025

Filed

Feb 3, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 30, 2025 · this disclosureInsiderCEO sold ~$41K of GUTS shares in the open market

What came next

1. Jan 30, 2025InsiderOfficer sold ~$42K of GUTS shares in the open market
2. Jan 31, 2025Insider · 2 peopleInsiders: 2 sales (~$206K)
3. Mar 13, 2025Insider · 3 peopleInsiders: 3 purchases (~$40K)
4. Mar 14, 2025Insider · 2 peopleInsiders: 2 purchases (~$63K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Fractyl Health

For Fractyl Health, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GUTS page.

Other recent filings by Harith Rajagopalan, Chief Executive Officer

• SEC Form 4 at Fractyl Health (GUTS)Dec 8, 2025
• SEC Form 4 at Fractyl Health (GUTS)Feb 3, 2025
• SEC Form 4 at Fractyl Health (GUTS)Nov 13, 2024

The full history of Harith Rajagopalan, Chief Executive Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Fractyl Health

• SEC Form 4Sep 16, 2026
• SEC Form 4Jun 15, 2026
• SEC Form 4Jun 11, 2026
• SEC Form 4Jun 11, 2026
• SEC Form 4Jun 9, 2026
• SEC Form 4Dec 8, 2025

Everything OQRO holds on this company is on its GUTS page.